OICR News / Tag

John Bartlett

Browse news tagged John Bartlett.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

CollaborationBreast cancer

OICR, Intensity Therapeutics and The Ottawa Hospital to conduct Window of Opportunity clinical trial in early-stage breast cancer

OICR, Intensity Therapeutics and The Ottawa Hospital have agreed to collaborate to conduct a Phase II randomized, window of opportunity (WOO) clinical trial evaluating an immunotherapy drug, called INT230-6 vs. the standard of care. Currently…

ArticleMar 24, 2021

TalentBreast cancer

OICR research team awarded $2.4 million to facilitate precision medicine for early-stage breast cancer

Partnership between Thermo-Fisher Scientific and OICR Diagnostic Development, led by Dr. John Bartlett, awarded support from Genome Canada’s Genomic Applications Partnership Program The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, has announced $8.6…

ArticleMar 09, 2021

Talent

OICR’s Dr. John Bartlett named one of the top-cited authors in the Journal of Clinical Oncology

The Journal of Clinical Oncology (JCO), one of the most prestigious journals in cancer research, recently added Dr. John Bartlett to its list of most-cited authors following an analysis by the analytics firm Clarivate. A…

ArticleFeb 17, 2021

TechnologyBreast cancer

Harnessing the time before a patient’s surgery to accelerate cancer research

Ottawa cancer researchers and clinicians embrace the window of opportunity between a cancer diagnosis and treatment with a coordinated approach to clinical research The time between a patient’s cancer diagnosis and their surgery presents a…

ArticleSep 20, 2019

CollaborationBreast cancer

Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing

Genome Canada, Ontario Institute for Cancer Research and Thermo Fisher Scientific to focus on pancreatic, prostate and breast cancer CARLSBAD, Calif. – (July 30, 2019) – Genome Canada, the Ontario Institute for Cancer Research (OICR)…

ArticleJul 30, 2019

TechnologyBreast cancer

Towards rational breast cancer treatment in the era of “less is more”

Expert researchers find shorter treatment cycles may reduce risk of breast cancer returning Researchers have found that the dosage and interval of chemotherapy treatments have a significant impact on some breast cancer patients’ survival. For…

ArticleMar 15, 2019

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

John Bartlett

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

OICR, Intensity Therapeutics and The Ottawa Hospital to conduct Window of Opportunity clinical trial in early-stage breast cancer

OICR research team awarded $2.4 million to facilitate precision medicine for early-stage breast cancer

OICR’s Dr. John Bartlett named one of the top-cited authors in the Journal of Clinical Oncology

Cancer solved together — in your inbox

Harnessing the time before a patient’s surgery to accelerate cancer research

Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing

Towards rational breast cancer treatment in the era of “less is more”